<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">44533066X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142736.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10689-010-9390-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10689-010-9390-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Cancer survivors: familial risk perception and management advice given to their relatives</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Francois Eisinger, Anne Bouhnik, Laetitia Malavolti, Anne Le Corroller-Soriano, Claire Julian-Reynier]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The aim of this study was to describe 2years cancer survivors' perception of the cancer risk running in their family, and to describe how frequently these survivors recommended cancer screening to their relatives. A national cross-sectional survey was launched by the French Ministry of Health to investigate the living conditions of adult cancer patients 2years after cancer diagnosis. Among the 13,923 patients identified, 6,957 were eligible to participate in this study and 4460 (64.1%) answered the questionnaire administered by telephone. One participant out of every two (50.8%) reported that they thought their relatives' risk of cancer was greater than that of the relatives of unaffected persons. Higher percentages were recorded among breast and colorectal cancer patients (65 and 65.1%, respectively), and lower percentages among those with lung and hematological cancer (34.9 and 28.4%, respectively). Overall, 61.1% of the participants had already advised relatives to undergo cancer screening and 10.4% planned to do so. Eighty-one percent of the participants with breast cancer and 76.3% of those with colorectal cancer said they had advised relatives to undergo screening. Lower percentages were obtained among patients with urinary tract (41.7%) and hematological malignancies (27.1%). Although patients' perceptions tend to fit the latest data on the frequency of cancer germline mutations, physicians should help their patients to convey more accurate advice to their families. If survivors were better informed, they could play a critical role by conveying relevant and sound risk reduction messages to their relatives.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media B.V., 2010</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Familial cancer</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Prevention</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Cancer family issues</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Screening</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Eisinger</subfield>
   <subfield code="D">Francois</subfield>
   <subfield code="u">UMR912, Institut Paoli-Calmettes, 232 Bd St Marguerite, 13009, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bouhnik</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Malavolti</subfield>
   <subfield code="D">Laetitia</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Le Corroller-Soriano</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Julian-Reynier</subfield>
   <subfield code="D">Claire</subfield>
   <subfield code="u">UMR912, Institut Paoli-Calmettes, 232 Bd St Marguerite, 13009, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Familial Cancer</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">10/1(2011-03-01), 147-155</subfield>
   <subfield code="x">1389-9600</subfield>
   <subfield code="q">10:1&lt;147</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">10</subfield>
   <subfield code="o">10689</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10689-010-9390-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10689-010-9390-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Eisinger</subfield>
   <subfield code="D">Francois</subfield>
   <subfield code="u">UMR912, Institut Paoli-Calmettes, 232 Bd St Marguerite, 13009, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bouhnik</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Malavolti</subfield>
   <subfield code="D">Laetitia</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Le Corroller-Soriano</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">INSERM, UMR 912, &quot;Economic &amp; Social Sciences, Health Systems &amp; Societies” (SE4S), 13273, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Julian-Reynier</subfield>
   <subfield code="D">Claire</subfield>
   <subfield code="u">UMR912, Institut Paoli-Calmettes, 232 Bd St Marguerite, 13009, Marseille, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Familial Cancer</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">10/1(2011-03-01), 147-155</subfield>
   <subfield code="x">1389-9600</subfield>
   <subfield code="q">10:1&lt;147</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">10</subfield>
   <subfield code="o">10689</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
